棒丝氨酸的全合成研究 Ⅰ.从D-葡萄糖合成3-[(3′R,5′S)-7′-氧代-1′-氮杂-4′-氧杂双环[3.2.0]-庚-3′-基]-3-O-苄基-(2S,3S)-丝氨酸及其(3′R,5′R)-差向异构体

以D-葡萄糖为原料经侧链氨基酸合成,与β-内酰胺缩合,嗯唑烷环合和除保护基等反应合成了棒丝氨酸的O-苄基衍生物,3-[(3′R,5′S)-7′-氧代-1-氮杂-4-氧杂双环[3.2.0]-庚-3′-基]-3-O-苄基-(2S,3S)-丝氨酸(17)及其(3′R,5′R)差向异构体(18)。     

比阿陪南双环母核的合成

从水杨酰胺出发,通过环合、酰化、Reformatsky反应、取代和Dieckmann环化反应,合成了碳青霉烯类抗生素比阿陪南的关键中间体--比阿陪南双环母核{(4R,5R,6S)-6-[(R)-1-叔丁基二甲基硅氧乙基]-3-二苯基磷酰氧基4-甲基-7-氧代-1-氮杂双环-[3.2.0]庚-2-烯-2-羧酸烯丙酯},总收率43.1%,其结构经1H NMR确证.     

(1R,3S,4S)-2-苄氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸的合成

以(R)-(+)-α-甲基苄胺为原料,依次经缩合,Diels-Alder反应,还原,Cbz-保护和水解反应,合成了抗丙肝新药HCV NS3/4A蛋白酶拟肽类抑制剂的重要中间体——(1R,3S,4S)-2-苄氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸,总收率66%,其结构经1H NMR和ESI-MS确证。     

棒丝氨酸的全合成研究I. 从D-葡萄糖合成3-[3'R, 5'S)-7'-氧代-1'-氮杂-4'-氧杂双环[3.2.0]-庚-3'-基]-3-O-苄基-(2S, 3S)-丝氨酸及其(3'R, 5'R)-差向异构体

以D-葡萄糖为原料经侧链氨基酸合成, 与β-内酰胺缩合, 唑烷环合和除保护基等反应合成了棒丝氨酸的O-苄基衍生物, 3-[3'R, 5'S)-7'-氧代-1'-氮杂-4'-氧杂双环[3.2.0]-庚-3'-基]-3-O-苄基-(2S, 3S)-丝氨酸及其(3'R, 5'R)-差向异构体(18)。     

棒丝氨酸的全合成研究I. 从D-葡萄糖合成3-[3'R, 5'S)-7'-氧代-1'-氮杂-4'-氧杂双环[3.2.0]-庚-3'-基]-3-O-苄基-(2S, 3S)-丝氨酸及其(3'R, 5'R)-差向异构体

以D-葡萄糖为原料经侧链氨基酸合成, 与β-内酰胺缩合, 唑烷环合和除保护基等反应合成了棒丝氨酸的O-苄基衍生物, 3-[3'R, 5'S)-7'-氧代-1'-氮杂-4'-氧杂双环[3.2.0]-庚-3'-基]-3-O-苄基-(2S, 3S)-丝氨酸及其(3'R, 5'R)-差向异构体(18)。     

1-氧代-1-磷杂-2, 6, 7-三氧杂双环[2.2.2]-4-含硫取代基辛烷 的合成

本文利用中间体1-氧代-1-磷杂2,6,7-三氧杂双环[2.2.2]-4-羟甲基辛烷(1)和1-氧代-1-磷杂-2,6,7-三氧杂双环[2.2.2]-4-氯甲酰基辛烷(3)分别与RSH或取代硫醇按步骤反应得到了相应的4-亚甲基硫醚(5a～f)、4-亚甲基亚砜(6a～f)、4-(氯代乙硫基)甲酰基(7)及4-(β-烷硫基)-α-硫代酯基(8a～i)的双环笼状磷酸酯新衍生物共22个。所有的化合物经元素分析、IR和^1HNMR得到了证实。     

2-O-苄基-3,5-内醚-α和β-D-木呋喃甲基甙的合成

本文报导一对具有2,6-二氧杂双环[3.2.0]庚烷骨架的四元环内醚型戊糖甙差向异构体的合成.其关键化合物2-O-苯甲基-3,5-二-O-对甲苯磺酰基-α-和β-D-木呋喃甲基甙(S)、2-O-苯甲基-5-O-对甲苯磺酰基-α-D-木呋喃甲基甙及其3-O-乙酰基衍生物均以结晶形固体制得,由这些结晶分别制得标题化合物.     

替拉瑞韦的合成工艺改进

(2S)-2-环己基-N-(2-吡嗪基羰基)甘氨酰-3-甲基-L-缬氨酸(2)与(1S,3aR,6a S)-八氢环戊烯并[c]吡咯-1-羧酸乙酯盐酸盐(3)缩合得到(1S,3aR,6a S)-2-((2S)-2-(((2S)-2-环己基-2-(吡嗪羰基)氨基)乙酰基)氨基)-3,3-二甲基-1-氧代丁基)-八氢环戊二烯并[c]吡咯-1-羧酸乙酯(5),5水解得到(1S,3aR,6a S)-2-((2S)-2-(((2S)-2-环己基-2-(吡嗪羰基)氨基)乙酰基)氨基)-3,3-二甲基-1-氧代丁基)-八氢环戊二烯并[c]吡咯-1-羧酸(6),此中间体再与(3S)-3-氨基-N-环丙基-2-羟基己酰胺盐酸盐(4)经过酰胺化、戴斯-马丁氧化得到替拉瑞韦(1),反应总收率为64%,HPLC色谱纯度99.9%。     

光学活性3-(1′-羟基乙基)-4-乙酰氧基-β-内酰胺的立体选择性合成

(1′R,3R,4R)-N-取代-3-(1′-羟基乙基)-4-乙酰氧基-β-内酰胺(3)是合成青霉烯和碳青霉烯类β-内酰胺抗生素的关键中间体.以廉价的L-抗坏血酸为原料,制得S-缩异丙氧叉甘油醛(5),与胺反应定量转变成相应的手性亚胺(6a～6d),6与双烯酮[2+2]环加成反应,高立体选择性地合成3(S)-乙酰基-β-内酰胺(Sa～8d),其非对映体过量由类似反应的80％提高到接近100％.8a经四步反应得到目标化合物3a.     

茚三酮比色法测定头孢羟氨苄

头孢羟氨苄化学名为(6R,7R)-3-甲基-7-[(R)-2-氨基-2-(4-羟基苯基)乙酰氨基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸一水合物,是第一代口服头孢菌素,对产青霉素酶和不产青霉素酶的金葡菌,凝固酶阴性葡萄球菌、肺炎链球菌、A组溶血性链球菌等大部分菌株具有良好的抗菌作用。对大肠埃希菌、奇异变形杆菌、沙门菌属、志贺菌属、流     

Comparison of various density functional methods for distinguishing stereoisomers based on computed (1)H or (13)C NMR chemical shifts using diastereomeric penam beta-lactams as a test set

Full (1)H and (13)C NMR chemical shift assignments were made for two sets of penam beta-lactams: namely, the diastereomeric (2S, 5S, 6S)-, (2S, 5R, 6R)-, (2S, 5S, 6R)-, and (2S, 5R, 6S)-methyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylates (1-4) and (2S, 5R, 6R)-, (2S, 5S, 6R)-, and (2S, 5R, 6S)-6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acids (6-8). Each penam was then modeled as a family of conformers obtained from Monte Carlo searches using the AMBER* force field followed by IEFPCM/B3LYP/6-31G(d) geometry optimization of each conformer using chloroform solvation. (1)H and (13)C chemical shifts for each conformer were computed at the WP04, WC04, B3LYP, and PBE1 density functional levels as Boltzmann averages of IEFPCM/B3LYP/6-311 + G(2d,p) energies over each family. Comparisons between experimental and theoretical chemical shift data were made using the total absolute error (|Deltadelta| (T)) criterion. For the (1)H shift data, all methods were sufficiently accurate to identify the proper stereoisomers. Computed (13)C shifts were not always successful in identifying the correct stereoisomer, regardless of which DFT method was used. The relative ability of each theoretical approach to discriminate among stereoisomers on the basis of proton shifts was also evaluated.     

Synthesis of novel fused β-lactams by intramolecular 1,3-dipolar cycloadditions. 3.1 6-phenoxyacetamido-7-oxo-1,3-diazabicyclo[3.2.0]heptaine-2-carboxylic acids

4-Methoxycarbonylmethylene-6-phenoxyacetamido-7-oxo-1,3-diazabicyclo[3.2.0]heptane-2-carboxylic acid and 4,7-dioxo-6-phenoxyacetamido-1,3-diazabicyclo[3.2.0]heptane-2-carboxylic acid have been prepared.     

A thermal decarbonylation of penam beta-lactams

Penam acids 6-8 [i.e., (2S,5R,6R)-, (2S,5S,6R)-, and (2S,5R,6S)-isomers of 6-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid] were prepared by deesterification of the corresponding methyl esters 2-4. The same methodology applied to ester 1 did not lead to the (2S,5S,6S)-isomer 5 but rather a 72% yield of the thiazoline derivative 9. High-resolution mass spectrometry analysis of the reaction headspace gases indicated that a stoichiometric amount of carbon monoxide is produced during the deesterification of 1. A mechanism for this decarbonylation reaction is proposed. This appears to represent a new type of fragmentation reaction for a penam carboxylic acid. The free energies of various reaction species along viable decarbonylation reaction coordinates for acids 5 and 7 were computed by using the density functional theory method IEFPCM/M06/6-31+G(d). Anionic and zwitterionic (neutral) variants of the proposed mechanism were considered, but each produced computed activation free energies deemed to be too high (>45 kcal/mol) to be experimentally relevant. The computed activation free energies for the protonated (cationic) variant of the mechanism were 17.3 kcal/mol for 7 vs 8.8 kcal/mol for 5. The value of this difference in energies of activation (DeltaDeltaG++) is quite consistent with experimental observations and supports the proposed mechanism. For a portion of the computed reaction coordinate that involves ring opening of the lactam ring by an internal carboxylic acid group to form a cyclic anhydride, the expected tetrahedral intermediate was circumvented by a direct (concerted) and facile N- to O-acyl migration event. Additional thermal gas-phase reaction products produced during gas chromatographic analysis of the penams 1-8 were characterized with high-resolution mass spectrometry, and possible mechanisms for their formation are presented.     

X-ray Structures of Three Penem Antibiotics: Molecular Mechanical and Dynamic Aspects

The structures of three -lactam penem antibiotics—i.e. the sodium[5R-[5,6(R*)]]-6-(1-hydroxyethyl)-7-oxo-3-[[(1-pyrrolidinylthioxomethyl)thio]methyl]-4-thia-1-azabicyclo[3.2.0] hept-2-ene-2-carboxylate (compound 1), the [5R-[3(S*),5,6(R*)]]-3-[[2-(aminocarbonyl)-1-pyrrolidinyl] methyl]-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (compound 2), and the [5R-[5,6(R*)]]-3-[[(2-amino-2-oxoethyl) methylamino]methyl]-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (compound 3)—have been determined by X-ray analyses. In the crystal lattice two conformational isomers of 1 are present, which differ from each other in the spatial arrangement of the dithiocarbamate chain. Compounds 2 and 3 are in zwitterionic form, being the hydrogen of the carboxylic acid moved to the amino nitrogen of the chain at C2. This hydrogen atom, in both molecules, forms intramolecular hydrogen bonds with an oxygen atom of the carboxylate moiety and with the oxygen atom of the amido group of the side chain. The 3D structures of 1, 2, and 3 have been compared with those of previously reported -lactam penem antibiotics. Particularly, the Woodward parameter and the Cohen distance, which are considered important in determining the antibiotic activity, have been discussed. Least-squares minimizations (RMS) of the distances between nuclei of selected pairs of atoms defining the pharmacological pattern have been performed, comparing five common antibiotics (imipenem, ritipenem, cephaloridine, amoxycillin, and benzylpenicillin) with our compounds. Finally, molecular dynamics calculations have been carried out on the three penem antibiotics at different temperatures. The conformational behavior of the hydroxyethyl chain, the carboxylate group, and the chain at C2 is discussed by considering the variation of some selected dihedral angles.     

New -lactam systems from penicillins

3-Isopropyl-4-thia-2,6-diazabicyclo[3.2.0]heptan-7-on ( 8 ), a potential intermediate for the synthesis of new β-lactam antibiotics [5], was prepared from the urethanes 7a and 9 by reduction with zinc/acetic acid. The cyclic Schiff base 10 , which constitutes an intermediate in this reaction, was prepared by reduction of 9 with CrCl² and was further reduced to 8 with zinc/acetic acid.     

Synthesis of racemic, 2-(alkylthio)-6-(1-hydroxyethyl) penems; attempted penem synthesis via copper (I) - promoted cyclisations

Stereocontrolled syntheses of the diastereoisomeric 6-(1-hydroxyethyl)-2-ethylthio and 2-(2-aminoethylthio)-penem-3-carboxylates from a common monocyclic azetidinone precursor are described. Cu (I)-promoted cyclisation of suitable N/C-3 secopenems is shown to yield “isopenems” (7-oxo-2-thia-1-azabicyc1o[3.2.0]-hept-3-enes) as the sole bicyclic product.     

Synthesis,crystal structure,and density functional theory study of a zinc(II) complex containing terpyridine and pyridine-2,6-dicarboxylic acid ligands: Analysis of the interactions with amoxicillin

An octahedral zinc(II) complex of 2,2′:6′,2″-terpyridine (Tpy) and pyridine-2,6-dicarboxylate (Pydc), [Zn(II)(Tpy)(Pydc)·4H₂O] was synthesized and its structure was determined by a single-crystal X-ray diffraction. The ligand pyridine-2,6-dicarboxylate coordinated to the zinc(II) ion via two pairs of carboxylate oxygens and one nitrogen atom, whereas 2,2′:6′,2″-terpyridine also contributed three coordination bonds through its nitrogen atoms. [Zn(II)(Tpy)(Pydc)·4H₂O] showed luminescence properties between 412 and 435 nm in DMSO. The solid-state octahedral geometry of [Zn(II)(Tpy)(Pydc)·4H₂O] was also preserved in solution as confirmed by the observed UV λ_ex = 346. Experimental and theoretical studies indicated that [Zn(II)(Tpy)(Pydc)·4H₂O] interacted with amoxicillin. Density functional theory calculations at B3LYP/LanL2dz level of theory suggested that [Zn(II)(Tpy)(pydc)·4H₂O] dimer interacts with (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)-acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-24-carboxylic acid (amoxicillin) via highest occupied molecular orbital and lowest unoccupied molecular orbital, π–π interaction, hydrogen bond interaction, and van der Waals forces, thus influencing [Zn(II)(Tpy)(Pydc)·4H₂O] properties.     

新型Bluco类β-内酰胺酶分子探针的合成

以2-氰基-6-羟基苯并噻唑为原料,与溴乙醛缩二乙醇缩合制得缩醛后再水解合成中间体6-(2-羰乙基)苯并[d]噻唑-2-甲腈(2);7-苯乙酰氨基-3-氯甲基头孢菌烷酸二苯甲酯依次经碘代和Wittig反应得(Z)-3-[3-(2-氰基苯并[d]噻唑-6-氧)丙-1-烯]-8-羰基-7-(2-苯乙酰氨基)-5-噻-1-氮[4.2.0]辛-2-烯-2-甲酸二苯甲酯(5);5经脱保护、缩合和氧化反应合成了3个新的Bluco类似物,其结构经1H NMR,13C NMR和HR-MS(ESI)表征。     

Synthesis and total 1H- and 13C-NMR assignment of cephem derivatives for use in ADEPT approaches

We report the synthesis and total NMR characterization of 5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic acid-3-[[[(4'-nitrophenoxy)carbonyl]oxy]-methyl]-8-oxo-7-[(2-thienyloxoacetyl)amino]-diphenylmethyl ester-5-dioxide (5), a new cephalosporin derivative. This compound can be used as the carrier of a wide range of drugs containing an amino group. The preparation of the intermediate product, 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid-3-[methyl 4-(6-methoxyquinolin-8-ylamino)pentylcarbamate]-8-oxo-7-[(2-thienyloxoacetyl)amino]-diphenylmethyl ester-5-dioxide (6), as well as the synthesis of the antimalarial primaquine prodrug 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid-3-[methyl 4-(6-methoxyquinolin-8-ylamino)pentylcarbamate]-8-oxo-7-[(2-thienyloxoacetyl)amino]- 5-dioxide (7) are also described, together with their total (1)H- and (13)C-NMR assignments.     

Synthesis of C3-Modified Carbapenems

Russian Journal of Organic Chemistry - Reactions of 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate with...